FUJIFILM Healthcare Americas Corporation has partnered with Singapore-based Us2.ai to integrate its automated echocardiography analysis software into Fujifilm’s LISENDO 880 cardiovascular ultrasound system.

The collaboration aims to address ongoing workforce shortages in cardiac imaging by automating time-intensive aspects of echocardiogram analysis. Us2.ai’s software uses AI to provide full cardiac measurements and reporting without manual input, analyzing 2D and Doppler images of all heart chambers in accordance with international clinical guidelines.

Us2.ai claims the platform can cut measurement and reporting time by up to 70% compared to traditional methods, citing findings published in the Journal of Echocardiography.
“Echo images are the gold standard for noninvasive cardiac imaging, however the average time to complete an exam can take anywhere from 40 to 90 minutes, plus reporting time,” said Hideyuki Honda, vice president of the ultrasound business unit at FUJIFILM Healthcare Americas Corporation. “AI has the ability to dramatically reduce this time burden, provide cardiologists with intelligent insights, and allow for more patients to get scanned.”

Echocardiography is widely regarded as one of the most effective tools for evaluating cardiac function, but the process remains manual and heavily dependent on skilled operators. This has contributed to growing backlogs in echo labs and variability in results due to operator technique.

“Performing echo looks a lot like it did 30 years ago and is long overdue for a solution to face the ever-increasing backlog of tests and the variability of the results due to it being highly manual,” said Seth Koeppel, head of business development at Us2.ai.

The Lexington, Massachusetts-based Fujifilm says the LISENDO 880 system with integrated AI is designed to support cardiologists and sonographers by accelerating workflows and standardizing image interpretation.

No timeline for deployment or regulatory approvals was disclosed.

Artificial Intelligence Homepage